Treatment

anti-CTLA-4 NF Probody® mAb clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Phase 1/2 First-in-human Study of BMS-986288 Alone and in Combination with Nivolumab in Advanced Malignant Tumors
This study is testing a new medicine, BMS-986288, alone and with another drug, nivolumab. It's for people with various advanced cancers. The main goals are to check for side effects and how well the new medicine works against the cancer.
For: Advanced solid tumors (squamous cell carcinoma of the head and neck (SCCHN) · non-small cell lung cancer (NSCLC) · cutaneous melanoma
Spain · France · Italy